NEW YORK (Reuters Health) - People who have spent more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a new study from ...

High-dose vitamin D reduced disease activity in early MS and CIS compared with placebo. Patients taking vitamin D had a longer time to disease activity: 432 days versus 224 days. No severe adverse ...

Depending on the type, some vitamins and minerals can be taken at any time of day, with or without food, while others require ...

Higher vitamin D levels were linked to a lower MS risk in White individuals, but the effect was weaker in Black individuals, suggesting that other biological mechanisms play a role in MS risk for ...

High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the ...